NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:NovoCure Ltd (NVCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014232
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovoCure Ltd (NovoCure) is an drug company that concentrates on the development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in various types of cancer indications such as ovarian cancer, malignant melanoma, hepatocellular carcinoma, breast cancer and small cell lung cancer, among others. It also offers products for other indications such as glioblastoma and diagnosed glioblastoma. Novocure operates along with its subsidiaries located in New Hampshire, the US; and Berlin, Germany. The company owns and operates a research centre in Haifa, Israel. It also has presence in Japan and Switzerland. NovoCure is headquartered in Jersey, the UK.

NovoCure Ltd (NVCR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
NovoCure Ltd, Medical Devices Deals, 2011 to YTD 2017 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
NovoCure Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novocure Enters into Research Agreement with MD Anderson Cancer Center 11
Equity Offering 12
NovoCure Raises USD95 Million in Public Offering of Series J Shares 12
NovoCure Raises USD194 Million in Public Offering of Series I Shares 13
NovoCure Raises USD55 Million in Public Offering of Series H Shares 14
NovoCure Raises USD44.1 Million in Public Offering of Shares 15
NovoCure Ltd – Key Competitors 16
NovoCure Ltd – Key Employees 17
NovoCure Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Oct 26, 2017: Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update 19
Jul 27, 2017: Novocure Reports Second Quarter 2017 Financial Results and Provides Company Update 22
Apr 27, 2017: Novocure Reports First Quarter 2017 Financial Results and Provides Company Update 25
Nov 02, 2016: Novocure Reports Third Quarter 2016 Financial Results and Provides Company Update 27
Jul 28, 2016: Novocure Reports Second Quarter 2016 Financial Results and Provides Company Update 30
Corporate Communications 33
May 11, 2017: Martin J. Madden Joins Novocure Board of Directors 33
May 11, 2016: Novocure Enters into Employment Agreement with William Doyle 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
NovoCure Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
NovoCure Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
NovoCure Ltd, Medical Devices Deals, 2011 to YTD 2017 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Novocure Enters into Research Agreement with MD Anderson Cancer Center 11
NovoCure Raises USD95 Million in Public Offering of Series J Shares 12
NovoCure Raises USD194 Million in Public Offering of Series I Shares 13
NovoCure Raises USD55 Million in Public Offering of Series H Shares 14
NovoCure Raises USD44.1 Million in Public Offering of Shares 15
NovoCure Ltd, Key Competitors 16
NovoCure Ltd, Key Employees 17
NovoCure Ltd, Other Locations 18
NovoCure Ltd, Subsidiaries 18

★海外企業調査レポート[NovoCure Ltd (NVCR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務情報
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Power Grid Corporation of India Ltd (POWERGRID EQ):企業の財務・戦略的SWOT分析
    Power Grid Corporation of India Ltd (POWERGRID EQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Michels Corp:企業の戦略・SWOT・財務情報
    Michels Corp - Strategy, SWOT and Corporate Finance Report Summary Michels Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Shinsung Solar Energy Co Ltd (011930)-エネルギー分野:企業M&A・提携分析
    Summary Shinsung Solar Energy Co., Ltd. (Shinsung Solar) is a provider of solar cells. Its products include single-crystalline and multi-crystalline solar cells, and mono-crystalline and multi-crystalline solar panels. Through its subsidiaries, the company offers installment financing, lease financi …
  • Sublimity Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sublimity Therapeutics Ltd(Sublimity) formerly known as Sigmoid Pharma Ltd, focuses on the development of therapeutics for unmet clinical needs in gastrointestinal and immunological diseases and disorders. The company’s product portfolio includes cyclosporine, oral vaccines, oral peptides an …
  • Nippon Paper Industries Co., Ltd.:企業の戦略・SWOT・財務情報
    Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Paper Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Deutsche Apotheker- und Arztebank:企業の戦略・SWOT・財務分析
    Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report Summary Deutsche Apotheker- und Arztebank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • EBSCO Industries Inc:企業の戦略的SWOT分析
    EBSCO Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Al Hassan Engineering Co (HECI):企業の財務・戦略的SWOT分析
    Al Hassan Engineering Co (HECI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • The Andersons Inc (ANDE):企業の財務・戦略的SWOT分析
    The Andersons Inc (ANDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ballard Power Systems Inc (BLDP):電力:M&Aディール及び事業提携情報
    Summary Ballard Power Systems Inc (Ballard Power) is a clean energy growth company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines …
  • Allianz Seguros SA:企業の戦略・SWOT・財務分析
    Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report Summary Allianz Seguros SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • RWE AG (RWE)-エネルギー分野:企業M&A・提携分析
    Summary RWE AG (RWE) is an energy company that generates, transmits and distributes electricity. The company generates electricity using various sources such as gas, hard coal, lignite, nuclear, hydro, biomass and renewables. It also produces oil, gas and lignite; and distributes and supplies gas. T …
  • Achem Technology Corporation:企業の戦略・SWOT・財務分析
    Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Enmax Corporation:発電所・企業SWOT分析
    Enmax Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務情報
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Guangxi Investment Group Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Guangxi Investment Group Co Ltd (Guangxi Investment) is a diversified company. The company’s business segments include energy, aluminium, financial, cultural tourism, international business and medical and medical health business. Its energy business provides investments in the construction …
  • Mitsubishi Motors Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Mountainview Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Mountainview Energy Ltd (MEL) is an oil and gas exploration and development company. The company explores, produces and develops oil and gas properties in eastern Montana and western North Dakota. It drills and explores oil and gas in the Williston Basin Bakken or Three Forks play and the So …
  • TE Connectivity Ltd (TEL):企業の財務・戦略的SWOT分析
    TE Connectivity Ltd (TEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆